4th Quarter - Report

AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY for AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY

Firm
Client
Income
—
Expenses
$118,352
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement issues, Merit-Based Incentive Payment System (MIPS), advanced alternative payment models (APMs), Quality Payment Program (QPP), misvalued codes, ambulatory surgery centers, ophthalmic legislation, FDA-related issues, compounded drug issues, quality issues, off-label communication, health information technology, healthcare reform, health insurer anti-trust issues, prior authorization and step therapy, evaluation & management codes, add-on codes.

LobbyistCovered position, as disclosed
NANCEY MCCANN Director of Government Relations

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.